Why is Remedium Life falling/rising?

As of 04-Jul, Remedium Lifecare Ltd's stock price is currently at 1.09, reflecting an increase of 0.01 or 0.93%. The stock has been on an upward trend, gaining for the last eight consecutive days with a total return of 29.76% during this period. Additionally, it has outperformed its sector by 8.64% today. However, despite this recent positive movement, the stock has experienced significant declines over the longer term, with a year-to-date drop of 69.50% and a staggering 91.05% decrease over the past year. The company faces serious challenges, including a high Debt to EBITDA ratio of -1.00 times, negative returns on capital employed (ROCE), and consistent losses reported over the last three quarters, which contribute to a perception of risk among investors. In the broader market context, while the Sensex has shown a modest gain of 6.77% year-to-date, Remedium Lifecare's performance starkly contrasts with this positive trend, highlighting its struggles. The stock's recent short-term gains are notable, particularly given that it has outperformed the sector despite a general decline in trading activity of -7.72%. This suggests that while there is some investor interest reflected in the increased delivery volume, the underlying financial health of the company remains a concern, which could limit its ability to sustain this upward momentum in the long run.